We show that in vivo USP30 inhibition, through genetic removal or small molecule inhibition, represents a viable strategy for enhancing the clearance of damaged mitochondria through mitophagy in this αSyn-based mouse PD model. This evidence concerns the gene USP30 and Parkinson disease.